Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.60)
# 862
Out of 4,981 analysts
454
Total ratings
42.4%
Success rate
8.48%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $36.89 | +8.43% | 7 | Sep 8, 2025 | |
| PSNL Personalis | Reiterates: Buy | $8.5 | $5.77 | +47.31% | 17 | Sep 8, 2025 | |
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $2.65 | +315.09% | 12 | Aug 21, 2025 | |
| PGEN Precigen | Reiterates: Buy | $8.5 | $3.86 | +120.21% | 13 | Aug 19, 2025 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $5 | $1.89 | +164.55% | 10 | Aug 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $50 → $66 | $55.87 | +18.13% | 9 | Aug 18, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.64 | +201.20% | 2 | Aug 18, 2025 | |
| AEMD Aethlon Medical | Reiterates: Neutral | $1.5 | $0.78 | +92.31% | 2 | Aug 14, 2025 | |
| VOR Vor Biopharma | Reiterates: Buy | $3 | $1.74 | +72.42% | 14 | Aug 14, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7 → $3.5 | $3.37 | +3.86% | 17 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.48 | +103.39% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $80 | $75.36 | +6.16% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $31 | $10.82 | +186.51% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $80.73 | +61.03% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.06 | +560.38% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $17.57 | +99.21% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $90 | $3.98 | +2,161.31% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $17.86 | +73.57% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.19 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.34 | +123.88% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.09 | +83.49% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $71.73 | +102.15% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $3.88 | +1,446.39% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $1.95 | +464.07% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.98 | +369.80% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.98 | +76.77% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.56 | +643.64% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.30 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.61 | +168.20% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.09 | +8,507.91% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.86 | +414.40% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.58 | +2,132.91% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.43 | +186.53% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $32.04 | +87.27% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $6.91 | +377.57% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.24 | +2,005.26% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.93 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.96 | +58.05% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.25 | +515.38% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.42 | +66.05% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.38 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.42 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.55 | +480.65% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.28 | +996.49% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.26 | +121.24% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $5.18 | +2,216.60% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.25 | +433.33% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.77 | +2,489.67% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.93 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $5.90 | +1.69% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.01 | +646.27% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.45 | +249.21% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $15.18 | -37.40% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.50 | +933,233.33% | 1 | Mar 5, 2020 |
Dianthus Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $40
Current: $36.89
Upside: +8.43%
Personalis
Sep 8, 2025
Reiterates: Buy
Price Target: $8.5
Current: $5.77
Upside: +47.31%
CollPlant Biotechnologies
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.65
Upside: +315.09%
Precigen
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $3.86
Upside: +120.21%
Pyxis Oncology
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.89
Upside: +164.55%
Celcuity
Aug 18, 2025
Maintains: Buy
Price Target: $50 → $66
Current: $55.87
Upside: +18.13%
Actuate Therapeutics
Aug 18, 2025
Reiterates: Buy
Price Target: $20
Current: $6.64
Upside: +201.20%
Aethlon Medical
Aug 14, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $0.78
Upside: +92.31%
Vor Biopharma
Aug 14, 2025
Reiterates: Buy
Price Target: $3
Current: $1.74
Upside: +72.42%
X4 Pharmaceuticals
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $3.37
Upside: +3.86%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.48
Upside: +103.39%
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $75.36
Upside: +6.16%
Aug 7, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $10.82
Upside: +186.51%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $80.73
Upside: +61.03%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.06
Upside: +560.38%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $17.57
Upside: +99.21%
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $3.98
Upside: +2,161.31%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $17.86
Upside: +73.57%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.19
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.09
Upside: +83.49%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $71.73
Upside: +102.15%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $3.88
Upside: +1,446.39%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $1.95
Upside: +464.07%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $2.98
Upside: +369.80%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.98
Upside: +76.77%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.56
Upside: +643.64%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.30
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.61
Upside: +168.20%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.09
Upside: +8,507.91%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.86
Upside: +414.40%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.58
Upside: +2,132.91%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $24.43
Upside: +186.53%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $32.04
Upside: +87.27%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $6.91
Upside: +377.57%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.24
Upside: +2,005.26%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.93
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.96
Upside: +58.05%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.25
Upside: +515.38%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.42
Upside: +66.05%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.38
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.42
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.55
Upside: +480.65%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.28
Upside: +996.49%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.26
Upside: +121.24%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $5.18
Upside: +2,216.60%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.25
Upside: +433.33%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.77
Upside: +2,489.67%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $13.93
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $5.90
Upside: +1.69%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.01
Upside: +646.27%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.45
Upside: +249.21%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $15.18
Upside: -37.40%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.50
Upside: +933,233.33%